EpiCongress: Norman Wong will speak 7/23.

Also for ESC Congress on August 30th, Norman Wong has a poster

RVX-208, an orally active BET inhibitor, lowers CVD risk by activities beyond raising ApoA-1/HDL.Norman WONG (Calgary, Canada)

I didn't find anything on the websites for the June 27th-June 30th conference or the July 28th to July 23 Alzheimer's conference regarding RVX posters/presentations. But I did not exhaustively search and sometimes abstracts are embargoed or restricted to registrered conference attendees. RVX has been good about doing news releases as they present at conferences, so I'm sure we will hear about it if they do present anything new. Sure would be nice timing around end of July to announce something big at the Alzheimer's or EpiCongress, right before the HepaLink deal is finalized.....